Lynda Charters

January 25, 2022

The meeting places a special emphasis on pharmacotherapies in the pipeline for the treatment of neovascular exudative diseases of the eye and how they will affect clinical practice and Medicare.

January 24, 2022

Approach shows potential as a promising second-line screening tool for patients with diabetes.

January 20, 2022

The improvement became evident during an average time of 6 months.

January 18, 2022

The investigators believe that, based on their findings, the impact of COVID-19 on the autonomous nervous system warrants further prospective studies and assessment of pupillary function might be a useful test for determining autonomic dysfunction.

January 17, 2022

Consecutive intravitreal dexamethasone treatments may be beneficial for patients with DME patients who had undergone a previous vitrectomy.

January 14, 2022

Imaging study revealed specific retinal and choroidal changes associated with the disease.

January 12, 2022

Investigators have cited the need for pharmacologic and non-pharmacologic interventions to improve the ongoing burden after hospitalization for COVID-19.

January 10, 2022

The difference in visual acuities based on CST fluctuations in these patients with diabetic macular edema remained significant.

January 07, 2022

The newly formed Bespoke Gene Therapy Consortium (BGTC) will team up to beat rare diseases that are currently using gene therapy.

December 20, 2021

A pilot study tests the technology to obtain remote fundus imaging of patients.